Of all the reasons to advertise in the New England Journal of Medicine, one stands out beyond all others: the editorial environment that surrounds your advertising message. NEJM is the most quoted medical journal in the world, with an unmatched reputation for reporting the most significant breakthroughs in medicine. Just 8% of manuscripts submitted are accepted for publication and none are reported in any other medium prior to publication in NEJM. You will find more information on NEJM editorial staff, editorial policies and information for authors below:
Click here to search the New England Journal of
Medicine site.
The New England Journal of Medicine has strict editorial policies governing the quality and originality of its content. These policies were established to protect the interests of our authors, readers and advertisers. Principal to our commitment is a policy known as the Ingelfinger Rule, which allows NEJM to consider a manuscript for publication only if its substance has not been submitted or reported elsewhere. This policy was promulgated in 1969 by the acting editor, Franz J. Ingelfinger and has been maintained by his successors.
NEJM editorial policies ensure advertisers that their message is
contained within unique and timely medical research. Additional
information and instructions are available in Information for Authors.
The New England Journal of Medicine’s guidelines for submission of articles are in accordance with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals." Click here for complete information and guidelines.